Cumberland Pharmaceuticals Inc. Disposal Group, Including Discontinued Operation, Operating Income (Loss)
Cumberland Pharmaceuticals Inc. (CPIX) reported Disposal Group, Including Discontinued Operation, Operating Income (Loss) of $1.99 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss · last filed 2022-03-11
- Cumberland Pharmaceuticals Inc. disposal group, including discontinued operation, operating income (loss) for fiscal 2021 was $1.99M, a 37.81% decline from fiscal 2020.
- Cumberland Pharmaceuticals Inc. disposal group, including discontinued operation, operating income (loss) for fiscal 2020 was $3.21M, a 43.39% decline from fiscal 2019.
- Cumberland Pharmaceuticals Inc. disposal group, including discontinued operation, operating income (loss) for fiscal 2019 was $5.67M, a 49.78% increase from fiscal 2018.
- Cumberland Pharmaceuticals Inc. disposal group, including discontinued operation, operating income (loss) for fiscal 2018 was $3.78M.
| Period end | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 12 month |
|---|---|
| 2021-12-31 | $1.99M 10-K · filed 2022-03-11 |
| 2020-12-31 | $3.21M 10-K · filed 2022-03-11 |
| 2019-12-31 | $5.67M 10-K · filed 2022-03-11 |
| 2018-12-31 | $3.78M 10-K · filed 2021-03-12 |
| 2017-12-31 | $4.80M 8-K · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |